The Health Science Center at UT Tyler refers to the health science education branch of the University of Texas at Tyler academic campus on U.S. Highway 271. UT Tyler HSC was chartered in 1977 by the University of Texas System Board of Regents. UTHSCT is the only academic medical centre in Northeast Texas.

During the past decade, The University of Texas Health Science Center at Tyler conducted 36 clinical trials. In the 10-year time frame, 36 clinical trials started and 24 clinical trials were completed, i.e. on average, 66.7% percent of trials that started reached the finish line to date. In the past 5 years, 16 clinical trials started and 19 clinical trials were completed. i.e. 118.8% of trials that started reached the finish line.

Out of the total clinical trials conducted in "The University of Texas Health Science Center at Tyler" #1 sponsor was "The University of Texas Health Science Center at Tyler" with 7 trials, followed by "Daiichi Sankyo, Inc." with 3 trials sponsored, "Gilead Sciences" with 3 trials sponsored, "Vertex Pharmaceuticals Incorporated" with 3 trials sponsored and "Baxalta now part of Shire" with 3 trials sponsored. Other sponsors include 34 different institutions and companies that sponsored additional 33 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "The University of Texas Health Science Center at Tyler" #1 collaborator was "Pfizer" with 4 trials as a collaborator, "The University of Texas Health Science Center at Tyler" with 4 trials as a collaborator, "AstraZeneca" with 3 trials as a collaborator, "Cystic Fibrosis Foundation" with 3 trials as a collaborator and "Daiichi Sankyo Co., Ltd." with 3 trials as a collaborator. Other collaborators include 49 different institutions and companies that were collaborators in the rest 51 trials.

According to Clinical.Site data, the most researched conditions in "The University of Texas Health Science Center at Tyler" are "Cystic Fibrosis" (8 trials), "Bronchiectasis" (4 trials), "Mycobacterium Avium Complex" (4 trials), "Breast Cancer" (3 trials) and "COVID-19" (3 trials). Many other conditions were trialed in "The University of Texas Health Science Center at Tyler" in a lesser frequency.

Most popular intervention types in "The University of Texas Health Science Center at Tyler" are "Drug" (42 trials), "Other" (9 trials), "Biological" (6 trials), "Behavioral" (4 trials) and "Device" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (18 trials), "AZLI" (3 trials), "Azithromycin" (3 trials), "Docetaxel" (2 trials) and "Placebo inhalation powder" (2 trials). Other intervention names were less common.

The vast majority of trials in "The University of Texas Health Science Center at Tyler" are 56 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "The University of Texas Health Science Center at Tyler". 1 are not yet recruiting, 9 are recruiting, 8 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 32 completed trials in The University of Texas Health Science Center at Tyler, undefined suspended trials, and 5 terminated clinical trials to date.

Out of the total trials that were conducted in The University of Texas Health Science Center at Tyler, 4 "Phase 1" clinical trials were conducted, 24 "Phase 2" clinical trials and 19 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 5 trials, and there were also 6 trials that are defined as “Not Applicable".